August Moretti
Overview
August Moretti received an average of $2M in total compensation, including $403K in salary, at 4D Molecular Therapeutics from 2019 to 2021.
Source: SEC filings on April 13, 2022 and April 6, 2021.
Related executives
We found six more executives who work or worked at 4D Molecular Therapeutics.
David Kirn
4D Molecular Therapeutics
Chief Executive Officer
Fariborz Kamal
4D Molecular Therapeutics
Chief Operating Officer
Robert Kim
4D Molecular Therapeutics
Chief Medical Officer
August Moretti
4D Molecular Therapeutics
Chief Financial Officer
Theresa Janke
4D Molecular Therapeutics
Chief of Staff
Robert Fishman
4D Molecular Therapeutics